In pancreatic cancer, systemic levels of IL-1β and IL-6 showed a trend towards the development of future thrombosis [ 44 ].
← all excerpts
Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with Glioma.
1
—
—